Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 57107
Gene Symbol: PDSS2
PDSS2
0.030 GeneticVariation phenotype BEFREE In addition to the genotypes of rs671, the patients were assessed with the PD sleep scale-2nd version (PDSS-2) and the Epworth sleepiness scale (ESS) for symptoms of daytime and nocturnal sleep disturbances. 31831791 2019
Entrez Id: 217
Gene Symbol: ALDH2
ALDH2
0.010 Biomarker phenotype BEFREE Effect of ALDH2 on Sleep Disturbances in Patients with Parkinson's Disease. 31831791 2019
Entrez Id: 3060
Gene Symbol: HCRT
HCRT
0.090 Biomarker phenotype BEFREE This review describes how neurotoxic and genetic manipulations of rats and mice have been utilized to reproduce some of the major sleep disturbances associated with PD and to what extent these abnormalities can be linked to nondopaminergic dysfunction, affecting for instance noradrenaline, serotonin, and orexin transmission. 31827439 2019
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.010 GeneticVariation phenotype BEFREE Then, we analyzed associations of IGF-1 variants with neuropsychiatric symptoms after mTBI, including anxiety, depression, dizziness, and sleep disturbances. 31787098 2019
Entrez Id: 4000
Gene Symbol: LMNA
LMNA
0.010 Biomarker phenotype BEFREE Individuals who sleep >7 hours/night with no trouble sleeping are 40% less likely to have severe periodontal disease (odds ratio [OR] = 0.6, P < 0.05), adjusting for age, sex, smoking status, FPL, education level, and dental visit. 31749207 2019
Entrez Id: 907
Gene Symbol: CCT
CCT
0.010 Biomarker phenotype BEFREE We assessed sleep disturbance repeatedly in: a) 523 adults with recurrent MDD who consented to 12-14 weeks of acute-phase cognitive therapy (A-CT) and b) 241 A-CT responders at elevated risk for depression relapse/recurrence who were randomized to 8 months of continuation-phase treatment (CCT vs. fluoxetine vs. matched pill placebo) and followed protocol-treatment-free for 24 months. 31735410 2020
Entrez Id: 3060
Gene Symbol: HCRT
HCRT
0.090 Biomarker phenotype BEFREE Orexin receptor antagonists may have therapeutic value in the treatment of insomnia, yet the use of this class of drugs in the treatment of sleep disturbances following adolescent alcohol exposure has not been studied. 31659377 2019
Entrez Id: 10261
Gene Symbol: IGSF6
IGSF6
0.010 Biomarker phenotype BEFREE This study showed that DORA-12 can affect the sleep disturbance that is associated with a history of adolescent ethanol exposure and also has several other sleep-promoting effects that are equivalent in both ethanol and control rats. 31659377 2019
Entrez Id: 6046
Gene Symbol: BRD2
BRD2
0.010 AlteredExpression phenotype BEFREE Recent studies have found altered levels of FSH, LH, and prolactin with sleep disturbance or circadian dysrhythmia. 31644470 2019
Entrez Id: 5617
Gene Symbol: PRL
PRL
0.010 Biomarker phenotype BEFREE Recent studies have found altered levels of FSH, LH, and prolactin with sleep disturbance or circadian dysrhythmia. 31644470 2019
Entrez Id: 7849
Gene Symbol: PAX8
PAX8
0.010 PosttranslationalModification phenotype BEFREE The accumulative effect of blast showed increased methylation of PAX8 antisense transcript with coordinated repression of gene expression, which has been associated with sleep disturbance. 31621494 2019
Entrez Id: 3060
Gene Symbol: HCRT
HCRT
0.090 Biomarker phenotype BEFREE These results identify a novel mechanistic link between mTOR and orexin in the hypothalamus related to sleep dysfunction and suggest a targeted therapeutic approach to sleep disorders in TSC. 31605778 2020
Entrez Id: 2475
Gene Symbol: MTOR
MTOR
0.010 Biomarker phenotype BEFREE These results identify a novel mechanistic link between mTOR and orexin in the hypothalamus related to sleep dysfunction and suggest a targeted therapeutic approach to sleep disorders in TSC. 31605778 2020
Entrez Id: 7248
Gene Symbol: TSC1
TSC1
0.010 AlteredExpression phenotype BEFREE Here, we characterized a mouse model of sleep disorders in TSC and investigated mechanisms of sleep dysfunction in this conditional knockout model involving inactivation of the Tsc1 gene in neurons and astrocytes (Tsc1<sup>GFAP</sup>CKO mice). 31605778 2020
Entrez Id: 10137
Gene Symbol: RBM12
RBM12
0.010 GeneticVariation phenotype BEFREE Monthly variation of hot flashes, night sweats, and trouble sleeping: effect of season and proximity to the Final Menstrual Period (FMP) in the SWAN Menstrual Calendar substudy. 31567864 2020
Entrez Id: 348
Gene Symbol: APOE
APOE
0.060 Biomarker phenotype BEFREE There was a sleep-APOE ε4 interaction (P = .001) in which patients with the APOE ε4 allele and sleep disturbances had significantly lower learning and memory scores than those who were APOE ε4-negative and without sleep disturbances. 31553501 2019
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.020 GeneticVariation phenotype BEFREE There was also a sleep disturbance-COMT genotype interaction (P = .02) in which COMT Val carriers with sleep disturbances had lower perceived cognition than noncarriers. 31553501 2019
Entrez Id: 1401
Gene Symbol: CRP
CRP
0.050 AlteredExpression phenotype BEFREE Regression analysis found that sleep disturbance predicted CRP levels and significance remained after adding covariates (β = 0.20, p = 0.04). 31546116 2019
Entrez Id: 79058
Gene Symbol: ASPSCR1
ASPSCR1
0.010 AlteredExpression phenotype BEFREE Higher GDS-scores and poorer TUG were independently associated with an overall level of poorer PF and global QoL throughout follow-up, as were more pain, dyspnea, and appetite loss, and sleep disturbance. 31444088 2019
Entrez Id: 4397
Gene Symbol: MS
MS
0.010 Biomarker phenotype BEFREE Our aim was to investigate the impact of the clinical features of the first clinical episode on cognitive disability and sleep dysfunction in MS. 31432354 2020
Entrez Id: 3060
Gene Symbol: HCRT
HCRT
0.090 AlteredExpression phenotype BEFREE Elevated orexin-A levels (p = 0.0183) in participants indicate sleep disturbance and circadian adaptation. 31426866 2019
Entrez Id: 23314
Gene Symbol: SATB2
SATB2
0.110 GeneticVariation phenotype BEFREE To determine the nature and frequency of behavioral phenotypes and sleep disturbances in individuals with SATB2-associated syndrome (SAS). 31420882 2019
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.050 Biomarker phenotype BEFREE <b>Conclusion:</b> Elevated IL-6 levels were observed in MDD patients and IL-6 may correlate with sleep disturbances. 31417262 2019
Entrez Id: 6513
Gene Symbol: SLC2A1
SLC2A1
0.110 Biomarker phenotype BEFREE The shortened period of NREM sleep and prolonged duration of the wake period may resemble the sleep disturbances commonly observed in patients with GLUT1DS and other epilepsy disorders. 31399478 2019
Entrez Id: 57107
Gene Symbol: PDSS2
PDSS2
0.030 Biomarker phenotype BEFREE The Parkinson's Disease Sleep Scale (PDSS-2) was used to identify sleep disturbances in a series of 229 PD patients. 31372031 2019